384 related articles for article (PubMed ID: 26359901)
1. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
Di Forti M; Marconi A; Carra E; Fraietta S; Trotta A; Bonomo M; Bianconi F; Gardner-Sood P; O'Connor J; Russo M; Stilo SA; Marques TR; Mondelli V; Dazzan P; Pariante C; David AS; Gaughran F; Atakan Z; Iyegbe C; Powell J; Morgan C; Lynskey M; Murray RM
Lancet Psychiatry; 2015 Mar; 2(3):233-8. PubMed ID: 26359901
[TBL] [Abstract][Full Text] [Related]
2. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
[TBL] [Abstract][Full Text] [Related]
3. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Ajnakina O; Gayer-Anderson C; Colizzi M; Quattrone D; Behlke I; Shetty S; McGuire P; David AS; Murray R; Bhattacharyya S
Lancet Psychiatry; 2016 Oct; 3(10):947-953. PubMed ID: 27567467
[TBL] [Abstract][Full Text] [Related]
4. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
[TBL] [Abstract][Full Text] [Related]
5. High-potency cannabis and the risk of psychosis.
Di Forti M; Morgan C; Dazzan P; Pariante C; Mondelli V; Marques TR; Handley R; Luzi S; Russo M; Paparelli A; Butt A; Stilo SA; Wiffen B; Powell J; Murray RM
Br J Psychiatry; 2009 Dec; 195(6):488-91. PubMed ID: 19949195
[TBL] [Abstract][Full Text] [Related]
6. Interaction between cannabis consumption and childhood abuse in psychotic disorders: preliminary findings on the role of different patterns of cannabis use.
Sideli L; Fisher HL; Murray RM; Sallis H; Russo M; Stilo SA; Paparelli A; Wiffen BDR; O'Connor JA; Pintore S; Ferraro L; La Cascia C; La Barbera D; Morgan C; Di Forti M
Early Interv Psychiatry; 2018 Apr; 12(2):135-142. PubMed ID: 26560802
[TBL] [Abstract][Full Text] [Related]
7. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
Quattrone D; Ferraro L; Tripoli G; La Cascia C; Quigley H; Quattrone A; Jongsma HE; Del Peschio S; Gatto G; ; Gayer-Anderson C; Jones PB; Kirkbride JB; La Barbera D; Tarricone I; Berardi D; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Tortelli A; Velthorst E; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Sham PC; Cardno AG; Vassos E; van Os J; Morgan C; Reininghaus U; Lewis CM; Murray RM; Di Forti M
Psychol Med; 2021 Jun; 51(8):1329-1337. PubMed ID: 32183927
[TBL] [Abstract][Full Text] [Related]
8. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.
Di Forti M; Sallis H; Allegri F; Trotta A; Ferraro L; Stilo SA; Marconi A; La Cascia C; Reis Marques T; Pariante C; Dazzan P; Mondelli V; Paparelli A; Kolliakou A; Prata D; Gaughran F; David AS; Morgan C; Stahl D; Khondoker M; MacCabe JH; Murray RM
Schizophr Bull; 2014 Nov; 40(6):1509-17. PubMed ID: 24345517
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis.
Fusar-Poli P; Rutigliano G; Stahl D; Davies C; Bonoldi I; Reilly T; McGuire P
JAMA Psychiatry; 2017 May; 74(5):493-500. PubMed ID: 28355424
[TBL] [Abstract][Full Text] [Related]
10. Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis.
Fusar-Poli P; Spencer T; De Micheli A; Curzi V; Nandha S; McGuire P
Eur Neuropsychopharmacol; 2020 Oct; 39():111-122. PubMed ID: 32921544
[TBL] [Abstract][Full Text] [Related]
11. Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial.
Holt RIG; Gossage-Worrall R; Hind D; Bradburn MJ; McCrone P; Morris T; Edwardson C; Barnard K; Carey ME; Davies MJ; Dickens CM; Doherty Y; Etherington A; French P; Gaughran F; Greenwood KE; Kalidindi S; Khunti K; Laugharne R; Pendlebury J; Rathod S; Saxon D; Shiers D; Siddiqi N; Swaby EA; Waller G; Wright S
Br J Psychiatry; 2019 Feb; 214(2):63-73. PubMed ID: 30251622
[TBL] [Abstract][Full Text] [Related]
12. IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use.
Ferraro L; Murray RM; Di Forti M; Quattrone D; Tripoli G; Sideli L; La Barbera D; La Cascia C
Schizophr Res; 2019 Aug; 210():81-88. PubMed ID: 31272907
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-potency cannabis on corpus callosum microstructure.
Rigucci S; Marques TR; Di Forti M; Taylor H; Dell'Acqua F; Mondelli V; Bonaccorso S; Simmons A; David AS; Girardi P; Pariante CM; Murray RM; Dazzan P
Psychol Med; 2016 Mar; 46(4):841-54. PubMed ID: 26610039
[TBL] [Abstract][Full Text] [Related]
14. Associations between physical multimorbidity patterns and common mental health disorders in middle-aged adults: A prospective analysis using data from the UK Biobank.
Ronaldson A; Arias de la Torre J; Prina M; Armstrong D; Das-Munshi J; Hatch S; Stewart R; Hotopf M; Dregan A
Lancet Reg Health Eur; 2021 Sep; 8():100149. PubMed ID: 34557851
[TBL] [Abstract][Full Text] [Related]
15. Admission to acute mental health services after contact with crisis resolution and home treatment teams: an investigation in two large mental health-care providers.
Werbeloff N; Chang CK; Broadbent M; Hayes JF; Stewart R; Osborn DPJ
Lancet Psychiatry; 2017 Jan; 4(1):49-56. PubMed ID: 27979719
[TBL] [Abstract][Full Text] [Related]
16. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.
Trotta G; Rodriguez V; Quattrone D; Spinazzola E; Tripoli G; Gayer-Anderson C; Freeman TP; Jongsma HE; Sideli L; Aas M; Stilo SA; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Tortelli A; Schürhoff F; Szöke A; Pignon B; Selten JP; Velthorst E; de Haan L; Llorca PM; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; Richards A; Rutten BP; Van Os J; Austin-Zimmerman I; Li Z; Morgan C; Sham PC; Vassos E; Wong C; Bentall R; Fisher HL; Murray RM; Alameda L; Di Forti M;
Psychol Med; 2023 Nov; 53(15):7375-7384. PubMed ID: 38078747
[TBL] [Abstract][Full Text] [Related]
17. Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study.
Patel R; Wilson R; Jackson R; Ball M; Shetty H; Broadbent M; Stewart R; McGuire P; Bhattacharyya S
BMJ Open; 2016 Mar; 6(3):e009888. PubMed ID: 26940105
[TBL] [Abstract][Full Text] [Related]
18. Tobacco use in first-episode psychosis, a multinational EU-GEI study.
Sánchez-Gutiérrez T; Rodríguez-Toscano E; Roldán L; Ferraro L; Parellada M; Calvo A; López G; Rapado-Castro M; La Barbera D; La Cascia C; Tripoli G; Di Forti M; Murray RM; Quattrone D; Morgan C; van Os J; García-Portilla P; Al-Halabí S; Bobes J; de Haan L; Bernardo M; Santos JL; Sanjuán J; Arrojo M; Ferchiou A; Szoke A; Rutten BP; Stilo S; D'Andrea G; Tarricone I; ; Díaz-Caneja CM; Arango C
Psychol Med; 2023 Nov; 53(15):7265-7276. PubMed ID: 37185055
[TBL] [Abstract][Full Text] [Related]
19. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
[TBL] [Abstract][Full Text] [Related]
20. [Cannabis use among hospitalized young people experiencing a first episode of psychosis: a case control study].
Castañeda CP; Alliende LM; Iruretagoyena B; Nachar R; Mancilla F; Díaz C; Gallardo C; Mena C; Ramírez-Mahaluf JP; Undurraga J; González-Valderrama A; Crossley NA
Rev Med Chil; 2020 Nov; 148(11):1606-1613. PubMed ID: 33844766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
